Our current study found that mMCP-1 released from mucosal MCs induced CD11b+Gr1+ cell accumulation and further amplified the potential of CD11b+Gr1+ cells to enhance tumor cell proliferation and inhibit T cell activation (Xu et al., 2015). Here, ITGAM is linked to neoplasm.